Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine–sirolimus interaction
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 70 (6), 1019-1025
- https://doi.org/10.1038/sj.ki.5001649
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- ABCB1 Genotype of the Donor but Not of the Recipient Is a Major Risk Factor for Cyclosporine-Related Nephrotoxicity after Renal TransplantationJournal of the American Society of Nephrology, 2005
- The Natural History of Chronic Allograft NephropathyNew England Journal of Medicine, 2003
- Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patientsKidney International, 2001
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyThe Lancet, 2000
- MECHANISMS OF NEPHROTOXICITYTransplantation, 2000
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosisKidney International, 1999
- Role of p-glycoprotein in chronic cyclosporine nephrotoxicity and its relationship to intrarenal angiotensin ii depositsTransplantation Proceedings, 1998
- SYNERGISTIC EFFECTS OF CYCLOSPORINE AND RAPAMYCIN IN A CHRONIC NEPHROTOXICITY MODEL1Transplantation, 1996
- Tubular-Derived Growth Factors and Cytokines in the Pathogenesis of Tubulointerstitial Fibrosis: Implications for Human Renal Disease ProgressionAmerican Journal of Kidney Diseases, 1994